Amphastar Pharmaceuticals, Inc. (AMPH) Stock Overview
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment…
Source: Yahoo Finance
Sector & Industry
Amphastar Pharmaceuticals, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NASDAQ exchange.
Amphastar Pharmaceuticals, Inc. at a Glance
| Company | Amphastar Pharmaceuticals, Inc. |
| Ticker | AMPH |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $23.18 |
| Market cap | $986.03M |
| P/E ratio (trailing) | 13.72 |
| EPS (trailing) | $1.69 |
| 52-week high | $29.52 |
| 52-week low | $16.65 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.92 |
| Return on equity (ROE) | 10.30% |
| Debt-to-equity | 89.61% |
| Average volume | 482,388 |
| Shares outstanding | 42.54M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 1,976 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is Amphastar Pharmaceuticals, Inc.'s current P/E ratio?
- Amphastar Pharmaceuticals, Inc. (AMPH) has a trailing P/E ratio of 13.72 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Amphastar Pharmaceuticals, Inc.'s market capitalisation?
- Amphastar Pharmaceuticals, Inc.'s market cap is $986.03M based on our latest snapshot. See how it ranks by market cap →
- What is AMPH's 52-week range?
- Over the past 52 weeks, AMPH has traded between $16.65 and $29.52. What does the 52-week range mean? →
- How volatile is Amphastar Pharmaceuticals, Inc. compared to the market?
- Amphastar Pharmaceuticals, Inc. has a beta of 0.92, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Amphastar Pharmaceuticals, Inc. pay a dividend?
- Amphastar Pharmaceuticals, Inc. does not currently pay a dividend according to our latest data.
- What exchange is AMPH listed on?
- AMPH is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Amphastar Pharmaceuticals, Inc. in?
- Amphastar Pharmaceuticals, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →